Yasser H. Wahab-Abdel
Cromore Road
Coleraine, NIR BT521SA, United Kingdom
Coleraine, NIR BT521SA, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Effects of long-acting analogues of lamprey GLP-1 and paddlefish glucagon on alpha- to beta-cell transdifferentiation in an insulin-deficient transgenic mouse model.
Journal: Journal of peptide science : an official publication of the European Peptide Society
Published: February 13, 2021
Beneficial actions of the [A14K] analog of the frog skin peptide PGLa-AM1 in mice with obesity and degenerative diabetes: A mechanistic study.
Journal: Peptides
Published: October 20, 2020
Glucagon from the phylogenetically ancient paddlefish provides a template for the design of a long-acting peptide with effective anti-diabetic and anti-obesity activities.
Journal: European journal of pharmacology
Published: October 29, 2019
A long-acting, dual-agonist analogue of lamprey GLP-1 shows potent insulinotropic, β-cell protective, and anorexic activities and improves glucose homeostasis in high fat-fed mice.
Journal: Molecular and cellular endocrinology
Published: May 13, 2019
Glucagon-related peptides from phylogenetically ancient fish reveal new approaches to the development of dual GCGR and GLP1R agonists for type 2 diabetes therapy.
Journal: Peptides
Published: September 25, 2018
Glucagon-like peptides-1 from phylogenetically ancient fish show potent anti-diabetic activities by acting as dual GLP1R and GCGR agonists.
Journal: Molecular and cellular endocrinology
Published: June 06, 2018
Evaluation of the insulinotropic and glucose-lowering actions of zebrafish GIP in mammalian systems: Evidence for involvement of the GLP-1 receptor.
Journal: Peptides
Published: October 19, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026